Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease

Journal of Neural Transmission

Volumn 107, Issue 1, 2000, Pages 59-71

  Giladi, N ^a,b   Treves, T A ^a   Paleacu, D ^a   Shabtai, H ^a   Orlov, Y ^a   Kandinov, B ^a   Simon, E S ^a   Korczyn, A D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Dementia; Depression; Parkinson's disease; Psychosis

Indexed keywords

AMANTADINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; SELEGILINE;

ADULT; AGED; ARTICLE; DELUSION; DEMENTIA; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STAGING;

EID: 0033955806     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050005     Document Type: Article

References (51)

1. th edn. APA, Washington DC
2. Biggins CA, Boyd JL, Harrop FM, Madeley P, Mindham RH, Randall JI, Spokes EG (1992) A controlled, longitudinal study of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 55: 566-571
3. Brown GL, Wilson WP (1972) Parkinsonism and depression. South Med J 65: 540-545
4. Brown RG, Marsden CD (1984) How common is dementia in Parkinson's disease? Lancet ii: 1262-1265
5. Cederbaum JM, Caudy SE, McDowell FH (1991) "Early" initiation of Ievoldopa treatment does not promote the development of motor response fluctuations, dyskinesias or dementia in Parkinson's disease. Neurology 41: 622-629
6. Celesia GG, Wanamaker WM (1972) Psychiatric disturbances in Parkinson's disease. Dis Nerv Syst 33: 577-583
7. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV (1991) Cognitive impairment in early untreated parkinson's disease and its relationship to motor disability. Brain 114: 2095-2122
8. Cummings JL (1992) Depression and Parkinson's disease: a review. Am J Psychiatry 149: 443-454
9. Dubois B, Pillon B, Sternic N et al. (1990) Age induced cognitive disturbances in Parkinson's disease. Neurology 40: 38-41
10. Ehnab TS, Beninger RJ, Gawel MJ, Riopelle RJ (1990) Depression symptoms in Parkinson's disease: a comparison with disabled control subjects. J Geriatr Psychiatry Neurol 2: 3-9
11. Fahn S (1997) Parkinsonism - Advanced Parkinson's disease: understanding and managing levolevodopa complication. In: Fahn S, Marsden CD, Jancovic J (eds) Comprehensive review of movement disorders for the clinical practitioner. Columbia University Press, pp 289-329
12. Fahn S, Elton RL, and members of the UPDRS Development Committee (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson's disease. Macmillan, New York
13. Galasko D, Hausen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill LR, Lessin P, Thal LY (1994) Clinical neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 51: 88-895
14. Goetz CG, Tanner CM, Klawans HL (1986) Drug holiday in the management of Parkinson's disease. Clin Neuropharmacol 9: 1-3
15. Goetz CG, Pappert EJ, Blasucci LM, Stebbins GT, Ling ZD, Nora MV, Carvey PM (1999) Intravenous levolevodopa infusions in chronically hallucinating Parkinson's disease patients: high-dose pharmacological challenge does not precipitate visual hallucinations. Neurology (in press)
16. Gotham AM, Brown RG, Marsden CD (1986) Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 49: 381-389
17. Hantz P, Caradoc-Davies C, Caradoc-Davies T, Weatherall M, Dixon G (1994) Depression in Parkinson's disease. Am J Psychiatry 151: 1010-1014
18. Hietamen M, Teravainen H (1988) The effect of age of disease onset on neuro-psycological performance in Parkinson's disease. J Neurol Neurosurg Psychiatry 51: 24-249
19. Hoehn MM, Yahr MD (1967) Parkinsonism onset progression and mortality. Neurology 17: 427-442
20. Horn S (1974) Some psychological factors in parkinsonism. J Neurol Neurosurg Psychiatry 37: 27-31
21. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease - a clinico pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184
22. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I and the Parkinson Study Group (1990) Variable expression of Parkinson's disease - a baseline analysis of the DATATOP cohort. Neurology 40: 1529-1534
23. Kish SJ, Shannak K, Rajput A, Deck JH, Hornykiewicz O (1992) Aging produces a specific pattern of striatal levodopamine loss: implications for the etiology of idiopathic Parkinson's disease. J Neurochem 58: 642-648
24. Korczyn AD, Yahr MD eds. (1979) Psychiatric side effects of anti-parkinson drugs. In: Nandy K (ed) Geriatric psychopharmacology. Elsevier North Holland, pp 157-170
25. Korczyn AD, Inzelberg R, Treves TA, Neufeld M, Reider I, Rabey MY (1986) Dementia of Parkinson's disease. In: Yahr MD, Bergman KJ (eds) Advances in neurology, vol 45. Raven Press, New York, pp 399-403
26. th International Congress of Parkinson's Disease and Movement Disorders, New York, October 10-14
27. Lesser RP, Fahn S, Snider SR, Cote LJ, Isgreen WP, Barret RE (1979) Analysis of the clinical problems in parkinsonism and the complications of long term dopa therapy. Neurology 29: 1253-1260
28. Ludin SM, Ludin HP (1989) Is Parkinson's disease of early onset a separate disease entity. J Neurol 236: 203-207
29. Markham CH, Diamond SG (1986) Long term follow-up of early levodopa treatment in Parkinson's disease. Ann Neurol 19: 365-372
30. Mayeux R, Stern Y, Rosen J, Leventhal J (1981) Depression, intellectual impairment, and Parkinson's disease. Neurology 31: 645-650
31. Mayeux R, Stern Y, Cote L, Williams JB (1984) Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 34: 642-646
32. Mayeux R, Stern Y, Rosenstein R, Marder K, Hauser A, Cote L, Fahn S (1988) An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Arch Neurol 45: 260-262
33. Mayeaux R, Denaro Y, Hemenegildo N, Marder K, Tang MX, Cote LY, Stern Y (1992) A population based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol 49: 492-497
34. Melamed E (1996) Neurobehavioral abnormalities in Parkinson's disease. In: Watts RL, Koller WC (eds) Movement disorders. McGraw Hill, New York, pp 257-262
35. Morttila RJ, Rinne UK (1976) Dementia in Parkinson's disease. Acta Neurol Scand 54: 431-441
36. Perry EK, Curtix M, Dick DJ, Caudy JM, Atack JR, Bloxman CA, Blessed G, Fairbairn A, Tomlison BE, Perry RH (1985) Cholinergic correlates of cognitive impairment in Parkinson's disease: comparison with Alzheimer disease. J Neurol Neurosurg Psychiatry 48: 413-421
37. Pillon B, Dubois B, Cusimans G, Bonnet A, Cusimano G, Lhermitte F, Agrid Y (1989) Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? J Neurol Neurosurg Psychiatry 52: 201-206
38. Quinn N (1994) Multiple system atrophy. In: Marsden CD, Fahn S (eds) Movement disorders 3. Butterworth-Heinemann, Oxford, pp 262-281
39. Sanchez-Ramos JR, Ortoll R, Paulson GW (1996) Visual hallucinations associated with Parkinson disease. Arch Neurol 53: 391-397
40. Santamaria J, Tolosa E, Valles A (1986) Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 36: 1130-1133
41. th edn. Iowa State University Press, pp 206-207
42. Starkstein S, Preziosi TJ, Berthier ML, Bolduc PL, Mayberg HS, Robinson RG (1989) Depression and cognitive impairment in Parkinson's disease. Brain 112: 1141-1153
43. Starkstein SE, Berthier JL, Bolduc PL, Preziosi TJ, Robinson RG (1989) Depression in patients with early versus late onset of Parkinson's disease. Neurology 39: 1441-1445
44. Stern Y, Marder K, Tang MX, Mayeux R (1993) Antecedent clinical features associated with dementia in Parkinson's disease. Neurology 43: 1690-1692
45. Stern MB (1997) Contemporary approaches to the pharmacotherapeutic management of Parkinson's disease: an overview. Neurology 49 [Suppl 1]: 52-59
46. Sweet RD, McDowell FH, Feigerson JS, Loranger AW, Goodell H (1976) Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology 26: 305-310
47. Tandberg E, Larsen JP, Aarsland D, Cummings JL (1996) The occurrence of depression in Parkinson's disease. Arch Neurol 53: 175-179
48. Tandberg E, Larsen JP, Aarsland D, Laake K, Cummings JL (1997) Risk factors for depression. Arch Neurol 54: 625-630
49. nd edn. Marcel Dekker, New York, pp 513-519
50. Troster AI, Stalp LD, Paolo AM, Fields JA, Koller WC (1995) Neuropsychological impairment in Parkinson's disease with and without depression. Arch Neurol 52: 1164-1169
51. Whitehouse PY, Hedreen JC, White CL, Price DL (1983) Basal fore brain neurons in the dementia of Parkinson's disease. Ann Neurol 13: 243-248